Blake Schutter Theil Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Sell
567
-52
-8% -$17.8K 0.14% 109
2026
Q1
$218K Sell
619
-3
-0.5% -$1.07K 0.18% 103
2025
Q4
$204K Buy
+622
New +$197K 0.17% 107

Other funds holding AMGN

Blake Schutter Theil Wealth Advisors's AMGN Position: Q2 2026 in Review

Blake Schutter Theil Wealth Advisors reduced its Amgen (AMGN) stake by 8.4% in Q2 2026, selling an estimated $17.8K and leaving 567 shares worth $205K. The position accounts for 0.14% of the portfolio, ranked #109.

Blake Schutter Theil Wealth Advisors first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $218K in Q1 2026. 1,326 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Blake Schutter Theil Wealth Advisors held 567 shares of Amgen worth $205K as of Q2 2026.
  • Blake Schutter Theil Wealth Advisors sold 52 Amgen shares in Q2 2026, an estimated $17.8K.
  • Amgen made up 0.14% of Blake Schutter Theil Wealth Advisors's portfolio in Q2 2026, its #109 holding.
  • Blake Schutter Theil Wealth Advisors first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Blake Schutter Theil Wealth Advisors's Amgen position peaked at $218K in Q1 2026.
  • 1,326 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Blake Schutter Theil Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.